Baudax Bio, Inc.

Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO in Pediatric Patients Following Surgery

MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX) recently announced the initiation of a clinical study evaluating the safety and pharmacokinetics (PK) of ANJESO (meloxicam) injection in pediatric patients (ages …

Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO in Pediatric Patients Following Surgery Read More

Windtree Therapeutics

Windtree Completes Enrollment in Its Phase 2 Study of Lucinactant for COVID-19 Associated Lung Injury and Acute Respiratory Distress Syndrome

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced it recently completed enrollment in its Phase 2 study of lucinactant (KL4 surfactant) for patients with COVID-19 associated lung injury and …

Windtree Completes Enrollment in Its Phase 2 Study of Lucinactant for COVID-19 Associated Lung Injury and Acute Respiratory Distress Syndrome Read More